Cathay Biotech Inc. (SHA:688065)
China
· Delayed Price · Currency is CNY 54.76
+1.85 (3.50%)
Mar 9, 2026, 3:00 PM CST
Cathay Biotech Revenue
In the year 2025, Cathay Biotech had annual revenue of 3.30B CNY with 11.41% growth. Cathay Biotech had revenue of 750.41M in the quarter ending December 31, 2025, with 1.02% growth.
Revenue
3.30B
Revenue Growth
+11.41%
P/S Ratio
11.57
Revenue / Employee
1.90M
Employees
1,764
Market Cap
38.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.30B | 337.54M | 11.41% |
| Dec 31, 2024 | 2.96B | 843.74M | 39.91% |
| Dec 31, 2023 | 2.11B | -326.93M | -13.39% |
| Dec 31, 2022 | 2.44B | 77.62M | 3.28% |
| Dec 31, 2021 | 2.36B | 866.29M | 57.86% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Inner Mongolia Berun Chemical Company | 11.55B |
| Chengxin Lithium Group | 4.18B |
| Do-Fluoride New Materials | 8.02B |
| Hubei Zhenhua Chemical | 4.29B |
| Hubei Xingfa Chemicals Group | 30.13B |
| FSPG Hi-Tech CO. | 2.25B |
| Weihai Guangwei Composites | 2.86B |
| Zhejiang Sanmei Chemical Industry | 5.43B |